{
    "eid": "2-s2.0-85114030323",
    "title": "Comparative long-term renal allograft outcomes of recurrent immunoglobulin a with severe activity in kidney transplant recipients with and without rituximab: An observational cohort study",
    "cover-date": "2021-09-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Medicine (all)",
            "@code": "2700",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Immunoglobulin A",
        "Kidney transplantation",
        "Recurrent glomerulonephritis",
        "Renal allograft outcomes",
        "Rituximab"
    ],
    "authors": [
        "Wiwat Chancharoenthana",
        "Asada Leelahavanichkul",
        "Wassawon Ariyanon",
        "Somratai Vadcharavivad",
        "Weerapong Phumratanaprapin"
    ],
    "citedby-count": 1,
    "ref-count": 45,
    "ref-list": [
        "Recurrent glomerulonephritis after kidney transplantation",
        "Exclusive characteristics of graft survival and risk factors in recipients with immunoglobulin A nephropathy: A retrospective analysis of registry data",
        "Recurrent IgA nephropathy in the renal allograft: Not a benign condition",
        "Evaluating the clinical course and prognostic factors of posttransplantation immunoglobulin a nephropathy",
        "The long-term outcome of renal transplantation of IgA nephropathy and the impact of recurrence on graft survival",
        "KDIGO clinical practice guideline for the care of kidney transplant recipients",
        "Kidney Disease: Improving Global Outcomes (2010). KDIGO clinical practice guideline for the care of kidney transplant recipients: A summary",
        "A clinicopatho-logical study of IgA nephropathy in renal transplant recipients: Beneficial effect of angiotensin-converting enzyme inhibitor",
        "Renin angiotensin system blockade in kidney transplantation: A systemic review of the evidence",
        "Recurrent IgA nephropathy after kidney transplantation",
        "Clinical features, treatment and prognostic factors of post-transplant immunoglobulin A nephropathy",
        "Use of anti-CD20 antibody in the treatment of post-transplant glomerulonephritis",
        "Rituximab therapy in early recurrent focal segmental sclerosis after renal transplantation",
        "Anti-CD20 monoclonal antibody (rituximab) for the treatment of recurrent idiopathic membranous nephropathy in a renal transplant patient",
        "Anti-CD20 monoclonal antibody (rituximab) for the treatment of membranous nephropathy after living-unrelated kidney transplantation: A case report",
        "Successful outcome using rituximab as the only immunomod-ulation in Henoch-Sch\u00d6nlein purpura: Case report",
        "Recurrent membranoproliferative glomerulonephritis after second renal graft treated with plasmapheresis and rituximab",
        "Successful treatment of nephrotic syndrome caused by recurrent IgA nephropathy with chronic active antibody-mediated rejection three years after kidney transplantation",
        "Recurrence of immunoglobulin A nephropathy after kidney transplantation: A narrative review of the incidence, risk factors, pathophysiology and management of immunosuppressive therapy",
        "Early recurrence of active IgA nephropathy after kidney transplantation",
        "A randomized, controoled trial of rituximab in IgA nephropathy with proteinuria and renal dysfunction",
        "Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity",
        "Rituximab for recurrent IgA nephropathy in kidney transplantation: A report of three cases and proposed mechanisms",
        "Classification of IgA nephropathy 2016: An update from the IgA Nephropathy Classification Working Group",
        "The Banff 97 working classification of renal allograft pathology",
        "Banff meeting report writing committee (2014). Banff 2013 meeting report: Inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions",
        "Kidney transplantation in patients with IgA mesangial glomerulonephritis",
        "Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies",
        "Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes",
        "Antithymocyte globulin (ATG) induction therapy and disease recurrence in renal transplant recipients with primary IgA nephropathy",
        "Recurrence of IgA nephropathy after kidney transplantation in steroid continuation versus early steroid-withdrawal regimens: A retrospective analysis of UNOS/OPTN database",
        "Steroids and recurrent IgA nephropathy after kidney transplantation",
        "Toronto Glomerulonephritis Registry. Remission of proteinuria improves prognosis in IgA nephropathy",
        "The clinical and pathological significance of borderline T cell-mediated rejection",
        "B cell-depleting therapy with rituximab or ofatumumab in immunoglob-ulin A nephropathy or vasculitis with nephritis",
        "B cells, antibodies, and more",
        "Mice overexpressing BAFF develop a commensal flora-dependent, IgA-associated nephropathy",
        "Rationale of anti-CD19 immunotherapy: An option to target autoreactive plasma cells in autoimmunity",
        "Increased miR-374b promotes cell proliferation and the production of aberrant glycosylated IgA1 in B cells of IgA nephropathy",
        "The effect of desensitization protocols on human splenic B-cell populations in vivo",
        "Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis",
        "Infectious complications of rituximab therapy in renal disease",
        "Prognostic value of serum biomarkers of autoimmunity for recurrence of IgA nephropathy after kidney transplantation",
        "Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis",
        "Impact of immunosuppressive medication on the risk of renal allograft failure due to recurrent glomerulonephritis"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199573",
            "affilname": "Faculty of Tropical Medicine, Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199573",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "109077978",
            "affilname": "Bangkok Nursing Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/109077978",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Mahidol University"
    ]
}